GUERRASIO, Angelo Cesare
GUERRASIO, Angelo Cesare
SCIENZE CLINICHE E BIOLOGICHE
Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience
2011-01-01 Saccardi; R; Sormani M; Di Gioia M; Bosi A; Cuneo A; Majolino I; Cavanna L; Ciceri F; Papineschi F; Mangoni M; La Nasa G; Pini M; Guerrasio A; Onida F; Gualandi F; Irrera G; Di Bartolomeo P; Donelli A; Gugliotta L; Vuolo L; Mancardi G.
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation.
2014-01-01 Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G
Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report
2016-01-01 De Mercanti, S; Durelli, L; Iudicello, M; Artusi, Ca; Barbero, P; Guerrasio, A; Clerico, M
Cytomegalovirus reactivation during alemtuzumab treatment in a patient with multiple sclerosis
2016-01-01 De Mercanti, S.F.; Durelli, L.; Iudicello, M.; Artusi, C.A.; Barbero, P.; Guerrasio, A.; Clerico, M.
Effects of PCSK9 inhibitors on platelet function in adults with hypercholesterolemia
2017-01-01 Barale, Cristina; Bonomo, Katia; Noto, Fabio; Traversa, Monica; Cavalot, Franco; Iozzia, Mirko; Frascaroli, Chiara; Guerrasio, Angelo; Russo, Isabella
GLP-1 reduces the activation of PI3K and MAPK pathways and of oxidative stress induced by Na-arachidonate in platelets.
2014-01-01 Barale C; Mattiello L; Cavalot F; Guerrasio A; Russo I.
Glucagon-Like Peptide 1 reduces platelet activation induced by sodium arachidonate through the inhibition of PI-3K and MAPK pathways.
2014-01-01 Barale C; Frascaroli C; Mattiello L; Cavalot F; Guerrasio A; Russo I.
Glucagon-Like Peptide 1 reduces platelet activation: effects on PI-3K and MAPK pathways and oxidative stress in the presence of arachidonic acid.
2014-01-01 Barale C; Mattiello L; Cavalot F; Guerrasio A; Russo I.
Ha-RAS haplotypes differences between peripheral blood leucocytes and tumor tissue in human breast cancer.
1987-01-01 Sismondi P; Camaschella ; Giai M; Serra A; Gasparini; Defabiani E; Guerrasio A; Biglia N; Peirone B; Mazza U; Saglio G.
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus
2015-01-01 Barale C; Cavalot F; Frascaroli C; Mattiello L; Guerrasio A; Russo I
In type 2 diabetes mellitus the GLP-1 effects on platelets are impaired.
2016-01-01 Barale C; Frascaroli C; Cavalot F; Guerrasio A; Russo I
Inhibition Of Bromodomain And Extra-Terminal (Bet) Proteins Increases Sensitivity To Venetoclax In Chronic Lymphocytic Leukemia
2019-01-01 Giovanna Carrà, Marcello Francesco Lingua, Beatrice Maffeo, Angelo Guerrasio, Giuseppe Saglio, Riccardo Taulli, Alessandro Morotti
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS
2015-01-01 G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia
2016-01-01 Giovanna Carrà, Cristina Panuzzo, Davide Torti, Guido Parvis, Sabrina Crivellaro, Marco Volante, Deborah Morena, Marcello Lingua, Mara Brancaccio, Angelo Guerrasio, Pier Paolo Pandolfi, Giuseppe Saglio, Riccardo Taulli, Alessandro Morotti
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS
2016-01-01 G Carrà, C Panuzzo, S Crivellaro, D Torti, G Parvis, U Familiari, M Volante, D Morena, MF Lingua, M Brancaccio, A Guerrasio, PP Pandolfi, G Saglio, R Taulli, A Morotti
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA
2015-01-01 S. Crivellaro, C. Panuzzo, G. Carrà, A. Volpengo, F. Crasto, E. Gottardi, A. Guerrasio, G. Saglio, A. Morotti
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA
2014-01-01 Crivellaro S; Panuzzo C; Carrà G; Familiari U; Gottardi E; Papotti M; Guerrasio A; Morotti A; Saglio G
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus
2015-01-01 Barale C; Cavalot F; Frascaroli C; Mattiello L; Guerrasio A; Russo I
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus.
2015-01-01 Barale C; Cavalot F; Mattiello L; Guerrasio A; Russo I
Resistenza agli effetti del GLP-1 sulla risposta pastrinica nel diabete di tipo 2
2016-01-01 Barale C; Cavalot F; Frascaroli C; Guerrasio A; Russo I
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience | 2011 | Saccardi; R; Sormani M; Di Gioia M; Bosi A; Cuneo A; Majolino I; Cavanna L; Ciceri F; Papineschi F; Mangoni M; La Nasa G; Pini M; Guerrasio A; Onida F; Gualandi F; Irrera G; Di Bartolomeo P; Donelli A; Gugliotta L; Vuolo L; Mancardi G. | |
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. | 2014 | Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G | |
Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report | 2016 | De Mercanti, S; Durelli, L; Iudicello, M; Artusi, Ca; Barbero, P; Guerrasio, A; Clerico, M | |
Cytomegalovirus reactivation during alemtuzumab treatment in a patient with multiple sclerosis | 2016 | De Mercanti, S.F.; Durelli, L.; Iudicello, M.; Artusi, C.A.; Barbero, P.; Guerrasio, A.; Clerico, M. | |
Effects of PCSK9 inhibitors on platelet function in adults with hypercholesterolemia | 2017 | Barale, Cristina; Bonomo, Katia; Noto, Fabio; Traversa, Monica; Cavalot, Franco; Iozzia, Mirko; Frascaroli, Chiara; Guerrasio, Angelo; Russo, Isabella | |
GLP-1 reduces the activation of PI3K and MAPK pathways and of oxidative stress induced by Na-arachidonate in platelets. | 2014 | Barale C; Mattiello L; Cavalot F; Guerrasio A; Russo I. | |
Glucagon-Like Peptide 1 reduces platelet activation induced by sodium arachidonate through the inhibition of PI-3K and MAPK pathways. | 2014 | Barale C; Frascaroli C; Mattiello L; Cavalot F; Guerrasio A; Russo I. | |
Glucagon-Like Peptide 1 reduces platelet activation: effects on PI-3K and MAPK pathways and oxidative stress in the presence of arachidonic acid. | 2014 | Barale C; Mattiello L; Cavalot F; Guerrasio A; Russo I. | |
Ha-RAS haplotypes differences between peripheral blood leucocytes and tumor tissue in human breast cancer. | 1987 | Sismondi P; Camaschella ; Giai M; Serra A; Gasparini; Defabiani E; Guerrasio A; Biglia N; Peirone B; Mazza U; Saglio G. | |
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus | 2015 | Barale C; Cavalot F; Frascaroli C; Mattiello L; Guerrasio A; Russo I | |
In type 2 diabetes mellitus the GLP-1 effects on platelets are impaired. | 2016 | Barale C; Frascaroli C; Cavalot F; Guerrasio A; Russo I | |
Inhibition Of Bromodomain And Extra-Terminal (Bet) Proteins Increases Sensitivity To Venetoclax In Chronic Lymphocytic Leukemia | 2019 | Giovanna Carrà, Marcello Francesco Lingua, Beatrice Maffeo, Angelo Guerrasio, Giuseppe Saglio, Riccardo Taulli, Alessandro Morotti | |
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS | 2015 | G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti | |
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia | 2016 | Giovanna Carrà, Cristina Panuzzo, Davide Torti, Guido Parvis, Sabrina Crivellaro, Marco Volante, Deborah Morena, Marcello Lingua, Mara Brancaccio, Angelo Guerrasio, Pier Paolo Pandolfi, Giuseppe Saglio, Riccardo Taulli, Alessandro Morotti | |
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS | 2016 | G Carrà, C Panuzzo, S Crivellaro, D Torti, G Parvis, U Familiari, M Volante, D Morena, MF Lingua, M Brancaccio, A Guerrasio, PP Pandolfi, G Saglio, R Taulli, A Morotti | |
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA | 2015 | S. Crivellaro, C. Panuzzo, G. Carrà, A. Volpengo, F. Crasto, E. Gottardi, A. Guerrasio, G. Saglio, A. Morotti | |
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA | 2014 | Crivellaro S; Panuzzo C; Carrà G; Familiari U; Gottardi E; Papotti M; Guerrasio A; Morotti A; Saglio G | |
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus | 2015 | Barale C; Cavalot F; Frascaroli C; Mattiello L; Guerrasio A; Russo I | |
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus. | 2015 | Barale C; Cavalot F; Mattiello L; Guerrasio A; Russo I | |
Resistenza agli effetti del GLP-1 sulla risposta pastrinica nel diabete di tipo 2 | 2016 | Barale C; Cavalot F; Frascaroli C; Guerrasio A; Russo I |